JO
BSTC

John Overdeck’s BioSpecifics Technologies Corp. BSTC Stock Holding History

John Overdeck’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,094
Closed -$782K – 3933
2019
Q2 		$782K Buy
+13,094
New +$824K ﹤0.01% 2156
2018
Q4 		– Sell
-19,646
Closed -$1.15M – 3718
2018
Q3 		$1.15M Buy
19,646
+3,011
+18% +$154K ﹤0.01% 1877
2018
Q2 		$746K Sell
16,635
-1,341
-7% -$57.7K ﹤0.01% 2360
2018
Q1 		$797K Buy
17,976
+1,651
+10% +$69.3K ﹤0.01% 2164
2017
Q4 		$707K Buy
16,325
+9,382
+135% +$422K ﹤0.01% 2203
2017
Q3 		$323K Sell
6,943
-2,162
-24% -$104K ﹤0.01% 2379
2017
Q2 		$451K Sell
9,105
-6,553
-42% -$343K ﹤0.01% 2411
2017
Q1 		$858K Sell
15,658
-12,369
-44% -$655K ﹤0.01% 2016
2016
Q4 		$1.56M Sell
28,027
-13,613
-33% -$654K 0.01% 1677
2016
Q3 		$1.9M Buy
41,640
+1,889
+5% +$75.9K 0.01% 1497
2016
Q2 		$1.59M Sell
39,751
-5,541
-12% -$203K 0.01% 1415
2016
Q1 		$1.58M Buy
45,292
+30,620
+209% +$1.12M 0.01% 1328
2015
Q4 		$630K Buy
+14,672
New +$735K ﹤0.01% 1822
2015
Q3 		– Sell
-29,297
Closed -$1.51M – 2920
2015
Q2 		$1.51M Buy
29,297
+9,618
+49% +$410K 0.01% 1377
2015
Q1 		$770K Sell
19,679
-17,587
-47% -$689K ﹤0.01% 1740
2014
Q4 		$1.44M Buy
37,266
+26,166
+236% +$998K 0.01% 1188
2014
Q3 		$392K Buy
+11,100
New +$326K ﹤0.01% 1385
2013
Q4 		– Sell
-12,111
Closed -$236K – 2456
2013
Q3 		$236K Buy
+12,111
New +$215K ﹤0.01% 1579

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

John Overdeck's BSTC Position: Q3 2019 in Review

John Overdeck sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2019, closing a stake of 13,094 shares — an estimated $782K sold.

John Overdeck first reported a position in BSTC in Q3 2013 and held it in 18 quarters. The position peaked at $1.9M in Q3 2016. 114 funds tracked by Wall St. Rank hold BSTC as of Q3 2019.

  • John Overdeck reported no remaining BioSpecifics Technologies Corp. position as of Q3 2019 after selling out during the quarter.
  • John Overdeck sold 13,094 BioSpecifics Technologies Corp. shares in Q3 2019, an estimated $782K.
  • John Overdeck first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 18 quarters.
  • John Overdeck's BioSpecifics Technologies Corp. position peaked at $1.9M in Q3 2016.
  • 114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2019.

Based on Two Sigma Investments's 13F filing for Q3 2019, filed 14 Nov 2019.